Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Immunity|January 22, 2013
Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptorDietmar M W Zaiss, Jorg van Loosdregt, Andrea Gorlani, et al.
Journal of Autoimmunity|April 15, 2020
CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosisMaarten van der Kroef, Tiago Carvalheiro, Marzia Rossato, et al.
Vaccine|September 4, 2012
Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in miceMary J G van Helden, Peter J S van Kooten, Cornelis P J Bekker, et al.
The Journal of Investigative Dermatology|August 1, 2021
ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal FibroblastsChiara Angiolilli, Emmerik F A Leijten, Cornelis P J Bekker, et al.
The Lancet. Rheumatology|May 20, 2026
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trialWing-Yi Wong, Dewi Rijnenberg, Valentin M D Baloche, et al.
Arthritis Research & Therapy|May 28, 2026
Circulating immune cell biomarkers in Psoriatic Arthritis: associations with clinical manifestations and treatment response in the TOFA-PREDICT trialF T Perton, J N Pouw, J Spierings, et al.
Frontiers in Immunology|October 12, 2020
CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells <i>in vitro</i>Sandra C Silva-Cardoso, Weiyang Tao, Chiara Angiolilli, et al.
Frontiers in Immunology|September 26, 2019
Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine ProductionMaarten R Hillen, Aridaman Pandit, Sofie L M Blokland, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 1998
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter studyE S Siris, A A Chines, R D Altman, et al.
RMD Open|August 2, 2023
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical responseSafae Hamkour, Eefje Hm van der Heijden, Ana P Lopes, et al.
Pageof 6